Thienopyridine NOX2 inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9029545
APP PUB NO 20120252805A1
SERIAL NO

13516252

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel NADPH oxidase II inhibitors and their use in the treatment of diseases mediated by the NADPH oxidase II enzyme.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLAXOSMITHKLINE INTELLECTUAL PROPERTY LIMITEDGSK MEDICINES RESEARCH CENTRE GUNNELS WOOD ROAD STEVENAGE SG1 2NY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Deborah Commonwealth, SG 9 111
Lee, Kiew Ching Commonwealth, SG 3 5
Terrell, Lamont Roscoe King of Prussia, US 5 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 12, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00